Stay updated on Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.

Latest updates to the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page
- Check7 days agoChange DetectedThere are no text changes detected in the provided data for this study page. The content remains as published, with no updates to study details, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, indicating a newer version of the page. This change reflects an update to revision metadata rather than substantive content changes.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new document revision tag v3.6.3 has been added, and the previous v3.6.2 tag was removed, indicating an updated set of study materials without changing the underlying study details.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.6.2 was added, replacing the previous Revision: v3.6.0. This reflects a small platform update with no visible changes to the study information.SummaryDifference0.1%

- Check50 days agoChange DetectedNo text changes are listed for the page. The current content is unchanged according to the input data.SummaryDifference0.1%

- Check57 days agoChange DetectedRecruitment status was updated to indicate that no new participants are being enrolled, clarifying the study's current accessibility. Navigation and labeling changes were made, including adding links such as How to Read a Study Record, Common Questions, How to Join a Study, and standardizing the Intervention/Treatment label, along with a revision version change from v3.5.5 to v3.6.0.SummaryDifference0.3%

Stay in the know with updates to Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.